Skip to main content
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
71.95
-3.50 (-4.64%)
At close: Feb 21, 2025, 4:00 PM
71.70
-0.25 (-0.35%)
After-hours: Feb 21, 2025, 7:57 PM EST

TransMedics Group Revenue

TransMedics Group had revenue of $108.76M in the quarter ending September 30, 2024, with 63.72% growth. This brings the company's revenue in the last twelve months to $401.09M, up 109.09% year-over-year. In the year 2023, TransMedics Group had annual revenue of $241.62M with 158.53% growth.

Revenue (ttm)
$401.09M
Revenue Growth
+109.09%
P/S Ratio
5.92
Revenue / Employee
$686,798
Employees
584
Market Cap
2.41B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 30, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

TMDX News

More News